NHLBI Announces Realignment of Its Sickle Cell Disease Research Program

March 10, 2008 – The National Heart, Lung, and Blood Institute (NHLBI) announced a comprehensive and innovative restructuring of its research program in sickle cell disease (SCD).

ASH submitted recommendations in response to NHLBI’s request for public information regarding the top scientific and clinical priorities in SCD. The Society is pleased to see many of its recommendations incorporated into the realignment.

ASH will be providing additional details about the NHLBI plan in upcoming announcements.